A Framework for Clinical Trials in Hereditary Hemorrhagic Telangiectasia–Associated Epistaxis—Navigating the PATH
This Viewpoint discusses how future clinical trials investigating the treatment of hereditary hemorrhagic telangiectasia could increase their efficacy by applying the insights gained from previous studies.
Authors
- Andrew M. Peterson (ORCID: https://orcid.org/0000-0001-9965-1572)
- Jay F. Piccirillo (ORCID: https://orcid.org/0000-0002-4062-1747)
- Murali M. Chakinala (ORCID: https://orcid.org/0000-0002-3782-341X)
Institutions
- Washington University in St. Louis (US)
- Office of Multidisciplinary Activities (US)
Publication Details
- Journal
- JAMA Otolaryngology–Head & Neck Surgery
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1001/jamaoto.2025.0017
- Citations
- 3
- Primary Topic
- Vascular Anomalies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.88